TD-8954

N/A

Report date: 2023/04/21 16:53:32
NME

Base Information

Drug NameTD-8954
Drug Alias Namefelcisetrag费西塞拉TD-8954TAK-954
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor agonists
TargetsSerotonin 4 (5-HT4) receptor
Therapy Area/IndicationsGastrointestinal motility disordersDiabetic GastroparesisEnteral Feeding Intolerance +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesSlovakia +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTheravance Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co LtdTakeda Development Center Americas Inc
Inactive CompaniesTheravance Biopharma IncMillennium Pharmaceuticals Inc
Active IndicationsGastrointestinal Diseases
Inactive IndicationsGastrointestinal motility disordersDiabetic GastroparesisEnteral Feeding Intolerance +[6] 

Other Information

ATC CodeN/A
Related LinksN/A